Navigation Links
New Jersey Center for Prostate Cancer & Urology Among First in Nation to Treat Advanced Prostate Cancer Patients with PROVENGE
Date:5/16/2011

MAYWOOD, N.J., May 16, 2011 /PRNewswire/ -- New Jersey Center for Prostate Cancer & Urology is among the first sites in the nation to treat advanced prostate cancer patients with PROVENGE® (sipuleucel-T), the first in a new therapeutic class known as autologous cellular immunotherapies.  PROVENGE was approved by the U.S. Food and Drug Administration (FDA) for the treatment of men with asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer and is made by Dendreon Corporation.

"PROVENGE is a revolutionary new treatment that may lead to similar personalized therapies in other cancer types," said Dr. Vincent Lanteri of NJ Center for Prostate Cancer & Urology. "We are pleased to have a new option to offer our patients and to be selected as one of the first facilities treating men with this important new therapy."

"PROVENGE allows patients to use their own cells to help fight cancer," said Dr. Michael Esposito.  "Patients with advanced prostate cancer now have a new option to prolong their lives.  I'm very excited about this and have high hopes for it."

PROVENGE is an autologous (made from a patient's own immune cells) cellular immunotherapy designed to stimulate a patient's immune system to identify and target prostate cancer cells. Each dose is manufactured specifically for each patient using his immune cells.

Individuals interested in learning whether PROVENGE is an appropriate treatment option should contact New Jersey Center for Prostate Cancer & Urology 201-487-8866 or call 1-877-336-3736.

About New Jersey Center for Prostate Cancer & Urology

The doctors of New Jersey Center for Prostate Cancer and Urology are undisputed experts in the field and have been recognized as 'Top Doctors' by New Jersey Monthly and New York Magazine and selected by Castle Connolly as 'Top Doctors for Cancer' in the country.  With locations in Northern and Central New Jersey, the practice offers patients needing prostate cancer or urological treatment easy access to state-of-the-art urological care close to home.  Offices are located at 255 W. Spring Valley Avenue, Maywood, NJ, at Holy Name Medical Center 718 Teaneck Road, Teaneck NJ, and at Monmouth Medical Center, 255 Third Avenue, Long Branch, NJ.  For more information about New Jersey Center for Prostate Cancer and Urology call (201) 487-8866 or visit www.RoboticUrology.com.


'/>"/>
SOURCE New Jersey Center for Prostate Cancer & Urology
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharma Elite to Unveil Latest Industry News/Program Agenda with 70+ Expert Speakers at Exclusive Event: Pharma CI Conference, September 13-14, 2011 in New Jersey
2. NeoStems Subsidiary Progenitor Cell Therapy Receives FACT Accreditation for Its New Allendale, New Jersey Manufacturing Facility
3. Bayer HealthCare Selects the State of New Jersey for East Coast Site Consolidation
4. Mesothelioma Litigation Attorney, Christopher Placitella to Lead Expert Panel on Mass Tort Litigation in New Jersey
5. Pharma ChemOutsourcing Targets BioNJ, PA Bio, MassBio, BayBio, SoCalBio, and NY Biotechnology Association Member Companies for September 2011 Show in New Jersey
6. Osteotechs Plexur M® Technology Wins Thomas Alva Edison Patent Award from the New Jersey Research and Development Council
7. Collagen Matrix, Inc. Expands Operations and Moves Corporate Headquarters to Oakland, New Jersey
8. First Live Web Chat by New Jerseys Princeton HealthCare System Focuses on Womens Health
9. Hospital Room of the Future Debuts in New Jersey
10. Curemark Opens Autism Trials at New Jersey Site
11. Big Pharma Chemists Turning Out in Large Numbers for ChemOutsourcing Extravaganza Event on September 14-16, 2010 at Jersey Shore Beach Resort
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
Breaking Medicine News(10 mins):